XPhyto Therapeutics (XPHY.C) announced today that its Good Manufacturing Practice (GMP) mescaline synthesis program is on schedule with the completion of initial production batches. Read full article here: https://equity.guru/2021/06/08/xphyto-therapeutics-xhpy-c-provides-progress-report-on-mescaline-program/
![Xphyto - 14-06 - Press Release Thumbnails](https://e4njohordzs.exactdn.com/wp-content/uploads/2021/06/Xphyto-14-06-Press-Release-Thumbnails-1024x576.png?strip=all&lossy=1&ssl=1)